Since the 1980s, when the number of families in Brazil headed by women almost doubled, the country has led an unpreceden ...

A major biotechnology company is exiting Silicon Valley and laying off more than 100 employees. The family-owned company ...

Investing.com -- Vir Biotechnology (NASDAQ:VIR) stock rose 3% after the company announced it has granted Norgine exclusive licensing rights for its hepatitis delta treatment in Europe, Australia, and ...

FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics” or the 'Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and ...

The JV was formed through Corteva Catalyst, Corteva’s investment and collaboration platform. Since its launch in March of ...

Viruses and bacteria get a bad rap around the world, but now Flinders University experts are identifying the positive "upside ...

The gene therapy developer has lost most of its value since going public in 2020 and saw a long road ahead for a delivery ...

Shares of Aldeyra Therapeutics were sharply lower in premarket trading Tuesday after the biotechnology company said the U.S. Food and Drug Administration's review of its proposed reproxalap treatment ...

2025 has been the best year for biotechs being acquired by pharma companies since 2019, with nearly $240 billion worth of ...

A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

As fossil fuels rise in cost and green initiatives gain traction, alternative methods for producing useful compounds using ...